Quidel | QDEL - Gewinn Vor Steuern





Gewinn Vor Steuern Veränderung Datum
Abbott USD 2.39B 27M 2026-03
Agilent USD 408M 44M 2026-03
Becton, Dickinson and Co. USD 39M 354M 2026-03
Bruker USD 117M 95.1M 2026-06
Cerus USD -20.76M 17.9M 2024-12
Charles River Laboratories USD -29.94M 264.16M 2026-03
Danaher USD 1.08B 157M 2026-06
Haemonetics USD 47.57M 75.97M 2026-06
Illumina USD 260M 103M 2026-06
IQVIA Holdings USD 301M 5.92B 2026-06
Merit Medical Systems USD 53.55M 2.49M 2026-03
Mettler Toledo International USD 209.66M 119.42M 2026-03
Myriad Genetics USD 4.6M 3.4M 2025-12
Neogen USD -20.3M 48.3M 2025-12
OraSure Technologies USD -18.43M 5.14M 2025-12
Pacific Biosciences Of California USD -40.17M 2.55M 2025-12
Quidel USD -79.5M 32.9M 2026-03
Revvity USD 187.24M 137.25M 2026-06
STAAR Surgical USD 8.22M 28.87M 2026-03
Thermo Fisher Scientific USD 1.73B 389M 2026-03
Waters USD 356M 444M 2026-06